| 000762 (2020) |
Mahmoud Gheblawi ; Kaiming Wang ; Anissa Viveiros ; Quynh Nguyen ; Jiu-Chang Zhong ; Anthony J. Turner [Royaume-Uni] ; Mohan K. Raizada ; Maria B. Grant ; Gavin Y. Oudit | Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System |
| 000760 (2020) |
Erkan Cure [Turquie] ; Medine Cumhur Cure [Turquie] | Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic |
| 000761 (2020) |
Haibo Zhang [République populaire de Chine, Canada] ; Josef M. Penninger [Autriche] ; Yimin Li [République populaire de Chine] ; Nanshan Zhong [République populaire de Chine] ; Arthur S. Slutsky [Canada, République populaire de Chine] | Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target |
| 000181 (2020) |
Gianluca Trifir [Italie] ; Salvatore Crisafulli [Italie] ; Giuseppe And [Italie] ; Giorgio Racagni [Italie] ; Filippo Drago [Italie] | Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? |
| 000185 (2020) |
Shu-Ren Li ; Zi-Jian Tang [République populaire de Chine] ; Zai-Han Li ; Xuan Liu [République populaire de Chine] | Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV |
| 000192 (2020) |
Sonja Gro [Allemagne] ; Christopher Jahn [Allemagne] ; Sarah Cushman [Allemagne] ; Christian B R [Allemagne] ; Thomas Thum [Allemagne] | SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications |
| 000216 (2020) |
Muthiah Vaduganathan ; Orly Vardeny ; Thomas Michel ; John J. V. Mcmurray ; Marc A. Pfeffer ; Scott D. Solomon | Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 |
| 000442 (2020) |
Reinhold Kreutz [Allemagne] ; Engi Abd El-Hady Algharably [Allemagne] ; Michel Azizi [France] ; Piotr Dobrowolski [Pologne] ; Tomasz Guzik [Pologne] ; Andrzej Januszewicz [Pologne] ; Alexandre Persu [Belgique] ; Aleksander Prejbisz [Pologne] ; Thomas Günther Riemer [Allemagne] ; Ji-Guang Wang [République populaire de Chine] ; Michel Burnier [Suisse] | Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19 |
| 000593 (2020) |
Andrew M. South [États-Unis] ; Laurie Tomlinson [Royaume-Uni] ; Daniel Edmonston [États-Unis] ; Swapnil Hiremath ; Matthew A. Sparks [États-Unis] | Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic |
| 000729 (2020) |
Eleanor Murray ; Maciej Tomaszewski [Royaume-Uni] ; Tomasz J. Guzik [Royaume-Uni] | Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications |
| 000763 (2020) |
Tonino Bombardini ; Eugenio Picano | Angiotensin converting enzyme 2 as the molecular bridge between epidemiologic and clinical features of COVID-19 |
| 000008 (2020) |
George Zaki Ghali [États-Unis] ; Michael George Zaki Ghali [États-Unis, Suède] | β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra-neuraxial carcinoma |
| 000106 (2020) |
Chi Zhang [République populaire de Chine] ; Zhao Wu [République populaire de Chine] ; Jia-Wen Li [République populaire de Chine] ; Hong Zhao [République populaire de Chine] ; Gui-Qiang Wang [République populaire de Chine] | The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality |
| 000086 (2020) |
Paolo Verdecchia ; Claudio Cavallini ; Antonio Spanevello ; Fabio Angeli | The pivotal link between ACE2 deficiency and SARS-CoV-2 infection |
| 000113 (2020) |
Peter P. Liu [Canada] ; Alice Blet [France] ; David Smyth [Canada] ; Hongliang Li [République populaire de Chine] | The Science Underlying COVID-19: Implications for the Cardiovascular System. |
| 000118 (2020) |
Farzad Taghizadeh-Hesary ; Hassan Akbari | The Powerful Immune System Against Powerful COVID-19: A Hypothesis |
| 000135 (2020) |
Pranab Bardhan | The Chinese governance system: Its strengths and weaknesses in a comparative development perspective |
| 000142 (2020) |
Rinkoo Dalan [Singapour] ; Stefan R. Bornstein [Singapour] ; Ali El-Armouche [Allemagne] ; Roman N. Rodionov [Allemagne] ; Alexander Markov [Russie] ; Ben Wielockx [Allemagne] ; Felix Beuschlein [Suisse] ; Bernhard O. Boehm [Singapour] | The ACE-2 in COVID-19: Foe or Friend? |
| 000215 (2020) |
Steven Nordin | Reply to the letter to the editor by Tuuminen et al. (2020), “Indoor air nontoxicity should be proven with special techniques prior claiming that it may cause a variety of mental disorders.” |
| 000287 (2020) |
Megan E. Marziali [Canada, États-Unis] ; Kiffer G. Card [Canada] ; Taylor Mclinden [Canada] ; Lu Wang [Canada] ; Jason Trigg [Canada] ; Robert S. Hogg [Canada] | Physical Distancing in COVID-19 May Exacerbate Experiences of Social Isolation among People Living with HIV |
| 000338 (2020) |
Abdo A. Elfiky [Égypte] | Natural products may interfere with SARS-CoV-2 attachment to the host cell. |
| 000360 (2020) |
Jian-Yin Qiu [République populaire de Chine] ; Dong-Sheng Zhou [République populaire de Chine] ; Jian Liu [République populaire de Chine] ; Ti-Fei Yuan [République populaire de Chine] | Mental Wellness system for COVID-19 |
| 000374 (2020) |
| May/June 2020 Forum |
| 000403 (2020) |
Duygu Aydemir [Turquie] ; Nuriye Nuray Ulusu [Turquie] | Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths? |
| 000416 (2020) |
Xuejiao Chen [République populaire de Chine] ; Junzhang Tian [République populaire de Chine] ; Guanming Li [République populaire de Chine] ; Guowei Li [République populaire de Chine, Canada] | Initiation of a new infection control system for the COVID-19 outbreak |
| 000461 (2020) |
Paul Carter [Royaume-Uni] ; Michael Anderson [Royaume-Uni] ; Elias Mossialos [Royaume-Uni] | Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective |
| 000505 (2020) |
Débora Da Luz Scheffer ; Alexandra Latini | Exercise-induced immune system response: Anti-inflammatory status on peripheral and central organs |
| 000517 (2020) |
Roberto Badagliacca [Italie] ; Susanna Sciomer [Italie] ; Nicola Petrosillo [Italie] | Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: friend or foe ? |
| 000529 (2020) |
Kevin A. Bobeck ; Arthur W. Holtzclaw ; Tara E. Brown ; Paul A. Clark | Effective Use of Angiotensin II in Coronavirus Disease 19–Associated Mixed Shock State: A Case Report |
| 000556 (2020) |
Lian Yong Li [République populaire de Chine] ; Wei Wu [République populaire de Chine] ; Sheng Chen [République populaire de Chine] ; Jian Wen Gu [République populaire de Chine] ; Xin Lou Li [République populaire de Chine] ; Hai Jing Song [République populaire de Chine] ; Feng Du [République populaire de Chine] ; Gang Wang [République populaire de Chine] ; Chang Qing Zhong [République populaire de Chine] ; Xiao Ying Wang [République populaire de Chine] ; Yan Chen [République populaire de Chine] ; Rushikesh Shah [États-Unis] ; He Ming Yang [République populaire de Chine] ; Qiang Cai [États-Unis] | Digestive system involvement of novel coronavirus infection: prevention and control infection from a gastroenterology perspective. |
| 000566 (2020) |
Krishnappa Ramya [Inde] ; Ramalingam Suresh [Inde] ; Honnavalli Yogish Kumar [Inde] ; B. R. Prashantha Kumar [Inde] ; N. B. Sridhara Murthy [Inde] | Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules |
| 000592 (2020) |
Adriano Sofo [Italie] ; Antonino Sofo [Italie] | Converting Home Spaces Into Food Gardens At the Time of Covid-19 Quarantine: All the Benefits of Plants in This Difficult and Unprecedented Period |
| 000623 (2020) |
Zhengdong Hu | China’s Blacklist System under the Covid-19 Precautionary Lockdown Regime |
| 000677 (2020) |
Ibrahim M. Ibrahim [Égypte] ; Doaa H. Abdelmalek [Égypte] ; Mohammed E. Elshahat [Égypte] ; Abdo A. Elfiky [Égypte, Arabie saoudite] | COVID-19 spike-host cell receptor GRP78 binding site prediction |
| 000718 (2020) |
Xiaoli Wang | COVID-19 Epidemic and Enhancing China’s National Biosecurity System |
| 000741 (2020) |
Jonathan Ripp ; Lauren Peccoralo ; Dennis Charney | Attending to the Emotional Well-Being of the Health Care Workforce in a New York City Health System During the COVID-19 Pandemic |
